Search Tag: Gamma Medica
2015 20 Aug
A Mayo Clinic study shows that molecular breast imaging (MBI) for women with dense breast tissue resulted in a lower cost per cancer detected than screening with mammography alone. MBI helped increase accuracy of breast cancer diagnosis, and in combination with mammography, resulted in cost savings of approximately 15 percent, according to the new study...Read more
2015 11 Jun
Gamma Medica, a leader in molecular breast imaging (MBI) technology, announced that Philip M. Croxford has been appointed as Chief Executive Officer. The company also named Scott Headland as its new Vice President of Sales. These executive changes align with Gamma Medica’s focus on commercialising its unique breast imaging technology for improved cancer...Read more